Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

NCT06289062 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Neoadjuvant Chemoimmunotherapy
Fertility Preservation

Interventions

DRUG: Camrelizumab
DRUG: Cisplatin
DRUG: Nab paclitaxel
PROCEDURE: biopsy

Sponsor

Tongji Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]